Abstract
Purpose
Pulmonary embolism with viable tumor cells developed after surgery for renal cell carcinoma may metastasize to lung. We investigated the incidence and fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus.
Methods
Among 4549 renal cell carcinoma patients treated with curative surgery at our institute from 1998 to 2015, 81 non-metastatic renal cell carcinoma patients with vena cava thrombus were included. The clinical course of pulmonary embolism and its impact on oncological outcomes were assessed.
Results
Postoperatively, pulmonary embolism developed in 13 patients (16.0%), who had higher level of vena cava thrombus (p = 0.004), more frequent liver mobilization (p = 0.005), and higher amount of intraoperative transfusion (p = 0.024) than patients without pulmonary embolism. The rate of lung metastasis was similar between patients with and without pulmonary embolism (30.8 vs. 35.3%, p = 1.000). In the multivariate analysis, the significant risk factors for disease recurrence were non-clear cell histology (p = 0.014) and larger primary renal tumor size (p = 0.032). Non-clear cell histology (p = 0.003) was the only significant risk factor for cancer-specific survival. Pulmonary embolism was not associated with both recurrence-free and cancer-specific survival.
Conclusions
Pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus was not associated with worse oncological outcomes and can be closely followed up with anticoagulation therapy.
Similar content being viewed by others
References
Bissada NK, Yakout HH, Babanouri A et al (2003) Long-term experience with management of renal cell carcinoma involving the inferior vena cava. Urology 61:89–92
Spiess PE, Kurian T, Lin HY et al (2012) Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy. BJU Int 110:E470–E474. doi:10.1111/j.1464-410X.2012.11155.x
Niedworok C, Dorrenhaus B, Vom Dorp F et al (2015) Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters. World J Urol 33:1541–1552. doi:10.1007/s00345-014-1449-4
Lue K, Russell CM, Fisher J et al (2016) Predictors of postoperative complications in patients who undergo radical nephrectomy and IVC thrombectomy: a large contemporary tertiary center analysis. Clin Genitourin Cancer 14:89–95. doi:10.1016/j.clgc.2015.09.007
Tilki D, Hu B, Nguyen HG et al (2015) Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. J Urol 193:436–442. doi:10.1016/j.juro.2014.07.087
Adibi M, Thomas AZ, Borregales LD, Matin SF, Wood CG, Karam JA (2015) Surgical considerations for patients with metastatic renal cell carcinoma. Urol Oncol 33:528–537. doi:10.1016/j.urolonc.2015.10.003
Motzer RJ, Jonasch E, Agarwal N et al (2015) Kidney cancer, version 3.2015. J Natl Compr Cancer Netw 13:151–159
Lardas M, Stewart F, Scrimgeour D et al (2015) Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena caval thrombus. Eur Urol. doi:10.1016/j.eururo.2015.11.034
Abel EJ, Margulis V, Bauman TM (2016) Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis. BJU Int 117:E87–E94. doi:10.1111/bju.13268
Abel EJ, Wood CG, Eickstaedt N et al (2013) Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol 190:452–457. doi:10.1016/j.juro.2013.02.033
Shuch B, Larochelle JC, Onyia T et al (2009) Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. J Urol 181:492–498. doi:10.1016/j.juro.2008.10.036 (discussion 498–499)
Chen H, Ng V, Kane CJ, Russell IA (2004) The role of transesophageal echocardiography in rapid diagnosis and treatment of migratory tumor embolus. Anesth Analg 99:357–359. doi:10.1213/01.ane.0000133001.42742.49 (table of contents)
Woodruff DY, Van Veldhuizen P, Muehlebach G, Johnson P, Williamson T, Holzbeierlein JM (2013) The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol 31:517–521. doi:10.1016/j.urolonc.2011.03.006
Streiff MB, Agnelli G, Connors JM et al (2016) Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis 41:32–67. doi:10.1007/s11239-015-1317-0
Nesbitt JC, Soltero ER, Dinney CP et al (1997) Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 63:1592–1600
Bertini R, Roscigno M, Freschi M et al (2011) Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma. Eur Urol 60:358–365. doi:10.1016/j.eururo.2011.05.029
Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H (2004) The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 94:33–41. doi:10.1111/j.1464-410X.2004.04897.x
Reese AC, Whitson JM, Meng MV (2013) Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol 31:1305–1309. doi:10.1016/j.urolonc.2011.12.006
Whitson JM, Reese AC, Meng MV (2011) Factors associated with surgery in patients with renal cell carcinoma and venous tumor thrombus. BJU Int 107:729–734. doi:10.1111/j.1464-410X.2010.09593.x
Pouliot F, Shuch B, Larochelle JC, Pantuck A, Belldegrun AS (2010) Contemporary management of renal tumors with venous tumor thrombus. J Urol 184:833–841. doi:10.1016/j.juro.2010.04.071 (quiz 1235)
Fred HL (2013) Unsuspected pulmonary thromboemboli: a continuing clinical challenge. Tex Heart Inst J 40:9–12
Klok FA, van der Hulle T, den Exter PL, Lankeit M, Huisman MV, Konstantinides S (2014) The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev 28:221–226. doi:10.1016/j.blre.2014.07.003
Fanikos J, Grasso-Correnti N, Shah R, Kucher N, Goldhaber SZ (2005) Major bleeding complications in a specialized anticoagulation service. Am J Cardiol 96:595–598. doi:10.1016/j.amjcard.2005.03.104
Kearon C (2003) Natural history of venous thromboembolism. Circulation 107:I22–I30. doi:10.1161/01.cir.0000078464.82671.78
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical standards
This study has been approved by the Institutional Review Board and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. IRB waived the mandate for obtaining legally effective informed consent from subjects. No information with the potential to disclose patient identities was included.
Conflicts of interest
The authors declare that they have no conflict of interest.
Human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Yoo, S., Song, S.H., Go, H. et al. Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus. Int Urol Nephrol 49, 1157–1163 (2017). https://doi.org/10.1007/s11255-017-1583-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-017-1583-1